Present and future of FDG-PET/CT in ovarian cancer

Kazuhiro Kitajima, Koji Murakami, Setsu Sakamoto, Yasushi Kaji, Kazuro Sugimura

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

Original languageEnglish
Pages (from-to)155-164
Number of pages10
JournalAnnals of Nuclear Medicine
Volume25
Issue number3
DOIs
Publication statusPublished - 2011 Apr

Fingerprint

Ovarian Neoplasms
Iodine
Contrast Media
Radiation
Neoplasms
Therapeutics

Keywords

  • FDG
  • Ovarian cancer
  • PET/CT
  • Restaging
  • Staging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kitajima, K., Murakami, K., Sakamoto, S., Kaji, Y., & Sugimura, K. (2011). Present and future of FDG-PET/CT in ovarian cancer. Annals of Nuclear Medicine, 25(3), 155-164. https://doi.org/10.1007/s12149-010-0449-8

Present and future of FDG-PET/CT in ovarian cancer. / Kitajima, Kazuhiro; Murakami, Koji; Sakamoto, Setsu; Kaji, Yasushi; Sugimura, Kazuro.

In: Annals of Nuclear Medicine, Vol. 25, No. 3, 04.2011, p. 155-164.

Research output: Contribution to journalArticle

Kitajima, K, Murakami, K, Sakamoto, S, Kaji, Y & Sugimura, K 2011, 'Present and future of FDG-PET/CT in ovarian cancer', Annals of Nuclear Medicine, vol. 25, no. 3, pp. 155-164. https://doi.org/10.1007/s12149-010-0449-8
Kitajima K, Murakami K, Sakamoto S, Kaji Y, Sugimura K. Present and future of FDG-PET/CT in ovarian cancer. Annals of Nuclear Medicine. 2011 Apr;25(3):155-164. https://doi.org/10.1007/s12149-010-0449-8
Kitajima, Kazuhiro ; Murakami, Koji ; Sakamoto, Setsu ; Kaji, Yasushi ; Sugimura, Kazuro. / Present and future of FDG-PET/CT in ovarian cancer. In: Annals of Nuclear Medicine. 2011 ; Vol. 25, No. 3. pp. 155-164.
@article{458ecb5a3cae426eb9c69d4ffc5b9674,
title = "Present and future of FDG-PET/CT in ovarian cancer",
abstract = "Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.",
keywords = "FDG, Ovarian cancer, PET/CT, Restaging, Staging",
author = "Kazuhiro Kitajima and Koji Murakami and Setsu Sakamoto and Yasushi Kaji and Kazuro Sugimura",
year = "2011",
month = "4",
doi = "10.1007/s12149-010-0449-8",
language = "English",
volume = "25",
pages = "155--164",
journal = "Annals of Nuclear Medicine",
issn = "0914-7187",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Present and future of FDG-PET/CT in ovarian cancer

AU - Kitajima, Kazuhiro

AU - Murakami, Koji

AU - Sakamoto, Setsu

AU - Kaji, Yasushi

AU - Sugimura, Kazuro

PY - 2011/4

Y1 - 2011/4

N2 - Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

AB - Integrated FDG-PET/CT has been used successfully for the diagnosis, staging, restaging, therapy monitoring and prognostic prediction of ovarian cancer as well as various other malignant tumors. Compared with conventional PET/non-contrast CT images, combined PET/ contrast-enhanced CT images with intravenous iodine contrast medium and sufficient radiation dose may contribute to a more accurate diagnosis with higher confidence. In the future, tracers other than FDG and integrated PET/ MRI will be realized. We herein review the place and role of FDG-PET/CT in the management of ovarian cancer, discussing its usefulness and limitations in the imaging of these patients.

KW - FDG

KW - Ovarian cancer

KW - PET/CT

KW - Restaging

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=79959992869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959992869&partnerID=8YFLogxK

U2 - 10.1007/s12149-010-0449-8

DO - 10.1007/s12149-010-0449-8

M3 - Article

VL - 25

SP - 155

EP - 164

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

SN - 0914-7187

IS - 3

ER -